Literature DB >> 16273765

Fibrinolytic activity and d-dimer levels in Behçet's syndrome.

S Yurdakul1, N Hekim, T Soysal, I Fresko, I Bavunoglu, F Ozbakir, F Tabak, M Melikoglu, V Hamuryudan, H Yazici.   

Abstract

OBJECTIVE: Thrombophlebitis occurs in a third of patients with Behçet's syndrome (BS). The thrombotic tendency in BS has been studied with inconclusive results perhaps due to the inadequate numbers of patients studied during the acute phase of the thrombosis as well as the lack of appropriate diseased controls. We have studied tissue-type plasminogen activator (t-PA) and its inhibitor (PAI-1), and d-dimer levels in BS patients with and without thrombosis both in the acute and chronic phases along with suitable diseased and healthy controls.
METHODS: t-PA and PAI-1 were studied by ELISA and d-dimer by semiquantitative latex agglutination slide test in 30 BS patients without deep vein thrombosis (DVT), 10 BS with acute DVT (ADVT), 25 BS with chronic DVT, 27 with ankylosing spondylitis, 26 diffuse systemic sclerosis, 15 patients with ADVT due to other causes, 10 patients with sepsis, and 23 healthy controls.
RESULTS: The t-PA levels in BS with ADVT were significantly lower than those in patients with ADVT due to other causes (7.4 +/- 6.2 vs. 13.4 +/- 6.3, P = 0.027) while PAI-1 levels did not show significant differences between the groups (P = 0.60). The numbers of patients with d-dimer levels of > or = 0.5 microg/ml in BS with ADVT were similar to those found in patients with ADVT due to other causes (9/10 vs. 14/14).
CONCLUSION: The relatively low t-PA levels point to a defect in fibrinolysis in BS. d-dimer levels are increased in the acute phase of thrombosis in BS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16273765

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

Review 1.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

2.  Behçet's Syndrome and Thrombosis.

Authors:  Emire Seyahi; Sebahattin Yurdakul
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-07-08       Impact factor: 2.576

3.  Behcet's Disease with Intracardiac Thrombus Presenting with Fever of Unknown Etiology.

Authors:  Sajal Ajmani; Durga Prasanna Misra; Deep Chandh Raja; Namita Mohindra; Vikas Agarwal
Journal:  Case Reports Immunol       Date:  2015-09-03

Review 4.  Behçet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils.

Authors:  Giacomo Emmi; Matteo Becatti; Alessandra Bettiol; Gülen Hatemi; Domenico Prisco; Claudia Fiorillo
Journal:  Front Immunol       Date:  2019-05-14       Impact factor: 7.561

5.  Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.

Authors:  Ihosvany Fernández-Bello; Francisco J López-Longo; Elena G Arias-Salgado; Víctor Jiménez-Yuste; Nora V Butta
Journal:  Orphanet J Rare Dis       Date:  2013-05-27       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.